Spectrum Wealth Advisory Group’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History
Bought
Maintained
Sold
Other funds holding FBT
SOS
RJFSA
BFG
Spectrum Wealth Advisory Group's FBT Position: Q3 2022 in Review
Spectrum Wealth Advisory Group sold out of First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q3 2022, closing a stake of 1,814 shares — an estimated $246K sold.
Spectrum Wealth Advisory Group first reported a position in FBT in Q2 2019 and held it in 13 quarters. The position peaked at $4.45M in Q3 2020. 218 funds tracked by Wall St. Rank hold FBT as of Q3 2022.
- Spectrum Wealth Advisory Group reported no remaining First Trust NYSE Arca Biotechnology Index Fund position as of Q3 2022 after selling out during the quarter.
- Spectrum Wealth Advisory Group sold 1,814 First Trust NYSE Arca Biotechnology Index Fund shares in Q3 2022, an estimated $246K.
- Spectrum Wealth Advisory Group first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q2 2019 and held it in 13 quarters.
- Spectrum Wealth Advisory Group's First Trust NYSE Arca Biotechnology Index Fund position peaked at $4.45M in Q3 2020.
- 218 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q3 2022.
Based on Spectrum Wealth Advisory Group's 13F filing for Q3 2022, filed 24 Oct 2022.